Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-24-037932

CEO sold 9,650 shares at $18.50 ($178,564)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-08-16 Sale : show line 1 in the form −9,650 $18.50 $178,564 718,419 D
Open-market sales · 9,650 sh · avg $18.50 · $178,564
Loading xslF345X05/form4.xml…